You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 4, April 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dementias
 •Motor Neuron Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Clinically Undetected Motor Neuron Disease in Pathologically Proven Frontotemporal Lobar Degeneration With Motor Neuron Disease

Keith A. Josephs, MST, MD; Joseph E. Parisi, MD; David S. Knopman, MD; Bradley F. Boeve, MD; Ronald C. Petersen, MD, PhD; Dennis W. Dickson, MD

Arch Neurol. 2006;63:506-512.

Background  Frontotemporal lobar degeneration with motor neuron disease (FTLD-MND) is a pathological entity characterized by motor neuron degeneration and frontotemporal lobar degeneration. The ability to detect the clinical signs of dementia and motor neuron disease in pathologically confirmed FTLD-MND has not been assessed.

Objectives  To determine if all cases of pathologically confirmed FTLD-MND have clinical evidence of frontotemporal dementia and motor neuron disease, and to determine the possible reasons for misdiagnosis.

Method  Review of historical records and semiquantitative analysis of the motor and extramotor pathological findings of all cases of pathologically confirmed FTLD-MND.

Results  From a total of 17 cases of pathologically confirmed FTLD-MND, all had clinical evidence of frontotemporal dementia, while only 10 (59%) had clinical evidence of motor neuron disease. Semiquantitative analysis of motor and extramotor pathological findings revealed a spectrum of pathological changes underlying FTLD-MND. Hippocampal sclerosis, predominantly of the subiculum, was a significantly more frequent occurrence in the cases without clinical evidence of motor neuron disease (P<.01). In addition, neuronal loss, gliosis, and corticospinal tract degeneration were less severe in the other 3 cases without clinical evidence of motor neuron disease.

Conclusions  Clinical diagnostic sensitivity for the elements of FTLD-MND is modest and may be affected by the fact that FTLD-MND represents a spectrum of pathological findings, rather than a single homogeneous entity. Detection of signs of clinical motor neuron disease is also difficult when motor neuron degeneration is mild and in patients with hippocampal sclerosis.


Author Affiliations: Departments of Neurology (Drs Josephs, Knopman, Boeve, and Petersen) and Laboratory Medicine and Pathology (Dr Parisi), Mayo Clinic, Rochester, Minn; Department of Pathology and Neuroscience (Dr Dickson), Mayo Clinic, Jacksonville, Fla.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Frontotemporal Lobar Degeneration With Motor Neuron Disease: A Clinical and Pathological Spectrum
Christopher M. Clark and Mark S. Forman
Arch Neurol. 2006;63(4):489-490.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapidly Progressive Neurodegenerative Dementias
Josephs et al.
Arch Neurol 2009;66:201-207.
ABSTRACT | FULL TEXT  

Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register
Kurian et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:84-87.
ABSTRACT | FULL TEXT  

Distinct genetic forms of frontotemporal dementia
Seelaar et al.
Neurology 2008;71:1220-1226.
ABSTRACT | FULL TEXT  

FRONTOTEMPORAL LOBAR DEGENERATION WITH UPPER MOTOR NEURON DISEASE/ PRIMARY LATERAL SCLEROSIS
Josephs and Dickson
Neurology 2007;69:1800-1801.
FULL TEXT  

TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
Seelaar et al.
Brain 2007;130:1375-1385.
ABSTRACT | FULL TEXT  

Rates of cerebral atrophy differ in different degenerative pathologies
Whitwell et al.
Brain 2007;130:1148-1158.
ABSTRACT | FULL TEXT  

Voxel-Based Morphometry in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With and Without Progranulin Mutations
Whitwell et al.
Arch Neurol 2007;64:371-376.
ABSTRACT | FULL TEXT  

A 34-year-old man with progressive behavioral and language disturbance
Miller et al.
Neurology 2007;68:68-74.
FULL TEXT  

Frontotemporal Lobar Degeneration Without Lobar Atrophy
Josephs et al.
Arch Neurol 2006;63:1632-1638.
ABSTRACT | FULL TEXT  

Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum.
Clark and Forman
Arch Neurol 2006;63:489-490.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.